{"disease":{"id":"prostate-intraductal-carcinoma","name":"prostate intraductal carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06662708","title":"Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shao Pengfei","has_results":false},{"nct_id":"NCT05053152","title":"Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":194,"lead_sponsor_name":"NRG Oncology","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}